Aflac Incorporated $AFL Shares Bought by Western Wealth Management LLC

Key Points

• Western Wealth Management increased its Aflac stake by 409.3% in the first quarter, owning 11,881 shares valued at approximately $1.3 million. Institutional investors and hedge funds collectively own 67.44% of Aflac.
• Aflac reported quarterly EPS of $1.75, slightly below the $1.76 consensus, while revenue of $4.22 billion exceeded estimates but declined 1% year over year. Analysts generally maintain a “Hold” view, with an average price target of $117.58.
• The company declared a quarterly dividend of $0.61 per share, equivalent to an annualized $2.44 payout and a 2.0% yield; the dividend is payable September 1 to shareholders of record on August 19.

Western Wealth Management LLC lifted its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 409.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 11,881 shares of the financial services provider's stock after acquiring an additional 9,548 shares during the period. Western Wealth Management LLC's holdings in Aflac were worth $1,303,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of AFL. Quarry LP bought a new stake in shares of Aflac during the fourth quarter valued at approximately $25,000. Groupe la Francaise bought a new position in Aflac in the 1st quarter worth approximately $25,000. Whipplewood Advisors LLC bought a new position in Aflac in the 1st quarter worth approximately $25,000. Nalls Sherbakoff Group LLC acquired a new stake in Aflac in the 4th quarter valued at approximately $29,000. Finally, Evergreen Advisors LLC acquired a new stake in Aflac in the 1st quarter valued at approximately $29,000. Institutional investors and hedge funds own 67.44% of the company's stock.

Aflac Price Performance

Shares of NYSE:AFL opened at $120.62 on Thursday. The stock has a market cap of $60.47 billion, a price-to-earnings ratio of 12.93, a PEG ratio of 1.95 and a beta of 0.60. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.12 and a quick ratio of 0.11. Aflac Incorporated has a 12 month low of $103.80 and a 12 month high of $130.22. The stock's 50 day moving average price is $121.18 and its 200 day moving average price is $115.68.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The financial services provider reported $1.75 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.76 by ($0.01). Aflac had a net margin of 26.91% and a return on equity of 13.27%. The firm had revenue of $4.22 billion for the quarter, compared to the consensus estimate of $4.11 billion. During the same period in the previous year, the business posted $1.78 earnings per share. The business's revenue for the quarter was down 1.0% compared to the same quarter last year. Equities research analysts anticipate that Aflac Incorporated will post 7.05 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 1st. Investors of record on Wednesday, August 19th will be paid a dividend of $0.61 per share. The ex-dividend date of this dividend is Wednesday, August 19th. This represents a $2.44 annualized dividend and a yield of 2.0%. Aflac's dividend payout ratio (DPR) is currently 26.15%.

Trending Headlines about Aflac

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $125 from $120 while maintaining a “market perform” rating, indicating limited but improved upside potential. Benzinga analyst rating update
• Positive Sentiment: Accident and health insurers, including Aflac, could benefit from increased underwriting exposure and greater digitalization. However, rising medical costs and inflation may pressure pricing. Zacks accident and health insurers outlook
• Neutral Sentiment: Wells Fargo kept a “hold” rating and a $120 price target, citing Aflac’s solid sector positioning but modest growth prospects and questions around mergers-and-acquisitions capital allocation. Wells Fargo Aflac rating
• Neutral Sentiment: Director Joseph L. Moskowitz sold 600 shares worth approximately $74,460 under a pre-arranged Rule 10b5-1 trading plan. The sale reduced his position by 1.8%, making it a limited insider-selling signal. Aflac insider transaction filing
• Negative Sentiment: JPMorgan lowered its price target to $116 from $117 and retained a “neutral” rating, implying downside from the referenced trading level. JPMorgan analyst rating update
• Negative Sentiment: Dowling & Partners cut its fiscal 2026 earnings-per-share estimate to $7.00 from $7.05, adding pressure after Aflac’s latest quarter slightly missed consensus EPS expectations and revenue declined year over year. Aflac earnings information

Insider Transactions at Aflac

In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 63,000 shares of the business's stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $118.12, for a total value of $7,441,560.00. Following the sale, the insider directly owned 51,169,435 shares in the company, valued at approximately $6,044,133,662.20. The trade was a 0.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 645,273 shares of company stock worth $75,599,007 over the last quarter. 0.80% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Mizuho set a $116.00 price target on Aflac in a research report on Monday. JPMorgan Chase & Co. lowered their price target on Aflac from $117.00 to $116.00 and set a "neutral" rating on the stock in a report on Tuesday. TD Cowen restated a "hold" rating and set a $110.00 price objective (up from $101.00) on shares of Aflac in a research note on Wednesday, July 22nd. Keefe, Bruyette & Woods upped their price objective on shares of Aflac from $120.00 to $125.00 and gave the stock a "market perform" rating in a report on Tuesday. Finally, Morgan Stanley increased their target price on shares of Aflac from $120.00 to $125.00 and gave the company an "equal weight" rating in a research report on Thursday, May 21st. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Aflac has an average rating of "Hold" and an average target price of $117.58.

Aflac Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac's product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source